NUVL Q1 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$53M

Net Income

-$44M

EPS (Diluted)

$-0.69

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$708M

Total Liabilities

$33M

Stockholders' Equity

$675M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$53M	-$30M	-74.1%
Net Income	-$44M	-$25M	-76.6%